Alex Makhnin

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0003-1998-7274

发表论文 72 篇 · 总被引 520 次 · h-index 10

代表论文

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer (2024 · Clinical Cancer Research · 被引 34)
A phase 2 basket trial of ado-trastuzumab emtansine for patients with HER2 amplified cancers. (2025 · Journal of Clinical Oncology · 被引 2)
Final results of a phase II study of cabozantinib in patients with MET -altered lung cancers. (2025 · Journal of Clinical Oncology · 被引 1)
A Phase II Basket Trial of Ado-Trastuzumab Emtansine for Patients with HER2 -Amplified Cancers: A Nonrandomized Clinical Trial (2026 · Clinical Cancer Research)
Supplemental Figure 3 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas (2025)
Supplemental Figure 2 from Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas (2025)